EFFICACY OF PIRIBEDIL AT DIFFERENT STAGES OF PARKINSON’S DISEASE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Piribedil reduces the degree of major motor symptoms, including the manifestations of motor fluctuations and drug-induced dyskinesia, as well as postural disorders, in Parkinson’s disease.

全文:

受限制的访问

作者简介

O. Troshlna

Voronezh Regional Clinical Hospital One

Email: onaumenko@mail.ru

T. Esina

Voronezh Regional Clinical Hospital One

Email: onaumenko@mail.ru

A. Chernyshova

Voronezh Regional Clinical Hospital One

Email: onaumenko@mail.ru

参考

  1. Диагностика и лечение экстрапирамидных расстройств. Под ред. В.Н. Штока / М., 2000; с. 138.
  2. Левин О.С., Федорова Н.В. Болезнь Паркинсона. 3-е изд. / М.: МЕДпресс-информ, 2012; 352 с.
  3. Кадыков А.С., Манвелов Л.С. Тесты и шкалы в неврологии: руководство для врачей / М.: МЕДпресс-информ, 2015; 224 с.
  4. Федорова Н.В., Чигирь И.П. Болезнь Паркинсона // Лечащий врач. -2005; 6: 34-40.
  5. Шток В.Н., Федорова Н.В. Лечение паркинсонизма / М., 1997; 194 с.
  6. Cohen G. Oxygen radicals and Parkinson's disease. Oxygen radicals and tissue injury. Ed. B. Halliwell / Federation of American Societies for Experimental Biology: Bethesda, MD, 1988; 130-5.
  7. Lang A. Are the new dopamine agonists better than the old ones? 6th International congress of Parkinson's disease and movement disorders Barcelona. Spain, 2000.
  8. Olanow C., Obeso J. Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors // Neurology. - 2000; 55 (4): 72-7.
  9. Parkers J., Baxter R., Marsden C. et al. Comparative trial benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease // J. Neural. Neurosurg. Psychiatry. - 1974; 37: 422-6.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2016